195 related articles for article (PubMed ID: 7796129)
21. Histamine in the locus coeruleus promotes descending noradrenergic inhibition of neuropathic hypersensitivity.
Wei H; Jin CY; Viisanen H; You HJ; Pertovaara A
Pharmacol Res; 2014 Dec; 90():58-66. PubMed ID: 25304183
[TBL] [Abstract][Full Text] [Related]
22. Sleep variables are unaltered by zolantidine in rats: are histamine H2-receptors not involved in sleep regulation?
Monti JM; Orellana C; Boussard M; Jantos H; Olivera S
Brain Res Bull; 1990 Aug; 25(2):229-31. PubMed ID: 1977498
[TBL] [Abstract][Full Text] [Related]
23. A role for histamine and H2-receptors in opioid antinociception.
Gogas KR; Hough LB; Eberle NB; Lyon RA; Glick SD; Ward SJ; Young RC; Parsons ME
J Pharmacol Exp Ther; 1989 Aug; 250(2):476-84. PubMed ID: 2547933
[TBL] [Abstract][Full Text] [Related]
24. Apomorphine-induced turning behavior in 6-hydroxydopamine lesioned rats is increased by histidine and decreased by histidine decarboxylase, histamine H1 and H2 receptor antagonists, and an H3 receptor agonist.
Liu CQ; Hu DN; Liu FX; Chen Z; Luo JH
Pharmacol Biochem Behav; 2008 Sep; 90(3):325-30. PubMed ID: 18452981
[TBL] [Abstract][Full Text] [Related]
25. Potentiation of 2-deoxy-D-glucose antinociception, but not hyperphagia by zolantidine, a histamine (H2) receptor antagonist.
Koch JE; Hough LB; Bodnar RJ
Pharmacol Biochem Behav; 1992 Feb; 41(2):371-6. PubMed ID: 1349437
[TBL] [Abstract][Full Text] [Related]
26. Activation of mesolimbic dopaminergic neurons following central administration of histamine is mediated by H1 receptors.
Fleckenstein AE; Lookingland KJ; Moore KE
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan; 347(1):50-4. PubMed ID: 8446183
[TBL] [Abstract][Full Text] [Related]
27. Zolantidine (SK&F 95282) is a potent selective brain-penetrating histamine H2-receptor antagonist.
Calcutt CR; Ganellin CR; Griffiths R; Leigh BK; Maguire JP; Mitchell RC; Mylek ME; Parsons ME; Smith IR; Young RC
Br J Pharmacol; 1988 Jan; 93(1):69-78. PubMed ID: 2894879
[TBL] [Abstract][Full Text] [Related]
28. Involvement of histaminergic system in the discriminative stimulus effects of morphine.
Mori T; Narita M; Onodera K; Suzuki T
Eur J Pharmacol; 2004 May; 491(2-3):169-72. PubMed ID: 15140633
[TBL] [Abstract][Full Text] [Related]
29. Actions of the brain-penetrating H2-antagonist zolantidine on histamine dynamics and metabolism in rat brain.
Hough LB; Jackowski S; Eberle N; Gogas KR; Camarota NA; Cue D
Biochem Pharmacol; 1988 Dec; 37(24):4707-11. PubMed ID: 3202904
[TBL] [Abstract][Full Text] [Related]
30. The differential effects of histamine receptor antagonists on morphine- and U-50,488H-induced antinociception in the mouse.
Suzuki T; Takamori K; Takahashi Y; Narita M; Misawa M; Onodera K
Life Sci; 1994; 54(3):203-11. PubMed ID: 7904710
[TBL] [Abstract][Full Text] [Related]
31. Effects of thioperamide, a histamine H3-receptor antagonist, on a scopolamine-induced learning deficit using an elevated plus-maze test in mice.
Miyazaki S; Imaizumi M; Onodera K
Life Sci; 1995; 57(23):2137-44. PubMed ID: 7475966
[TBL] [Abstract][Full Text] [Related]
32. Different effects of the histamine H2 receptor blockers, famotidine and zolantidine, on the human atrium in vitro.
Poli E; Pozzoli C; Barboso G; Bertaccini G
Arch Int Pharmacodyn Ther; 1994; 328(2):180-90. PubMed ID: 7710303
[TBL] [Abstract][Full Text] [Related]
33. Effects of clobenpropit (VUF-9153), a histamine H3-receptor antagonist, on learning and memory, and on cholinergic and monoaminergic systems in mice.
Miyazaki S; Onodera K; Imaizumi M; Timmerman H
Life Sci; 1997; 61(4):355-61. PubMed ID: 9244361
[TBL] [Abstract][Full Text] [Related]
34. Cognitive involvement by negative modulation of histamine H2 receptors in passive avoidance task in mice.
Onodera K; Miyazaki S; Imaizumi M
Methods Find Exp Clin Pharmacol; 1998 May; 20(4):307-10. PubMed ID: 9658380
[TBL] [Abstract][Full Text] [Related]
35. Differential role of histamine in mediating stress-induced changes in central dopaminergic neuronal activity in the rat.
Fleckenstein AE; Lookingland KJ; Moore KE
Brain Res; 1994 Aug; 653(1-2):267-72. PubMed ID: 7982060
[TBL] [Abstract][Full Text] [Related]
36. Effects of thioperamide, a histamine H3 receptor antagonist, on locomotor activity and brain histamine content in mast cell-deficient W/Wv mice.
Sakai N; Onodera K; Maeyama K; Yanai K; Watanabe T
Life Sci; 1991; 48(25):2397-404. PubMed ID: 1675414
[TBL] [Abstract][Full Text] [Related]
37. Aggravation of ischemic neuronal damage in the rat hippocampus by impairment of histaminergic neurotransmission.
Adachi N; Oishi R; Itano Y; Yamada T; Hirakawa M; Saeki K
Brain Res; 1993 Jan; 602(1):165-8. PubMed ID: 8095425
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of naloxone-resistant antinociception by centrally administered H2-antagonists.
Gogas KR; Hough LB
J Pharmacol Exp Ther; 1989 Jan; 248(1):262-7. PubMed ID: 2563290
[TBL] [Abstract][Full Text] [Related]
39. Suppression of morphine-induced conditioned place preference by l-12-chloroscoulerine, a novel dopamine receptor ligand.
Liu ZH; Jin WQ; Zhang HP; Chen XJ; Jin GZ
Pharmacol Biochem Behav; 2003 May; 75(2):289-94. PubMed ID: 12873618
[TBL] [Abstract][Full Text] [Related]
40. Importance of histamine H2 receptors in restraint-morphine interactions.
Nalwalk JW; Hough LB
Life Sci; 1995; 57(13):PL153-8. PubMed ID: 7674814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
